67
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Effectiveness and Safety of Anlotinib Combined with PD-1 Blockades in Patients with Previously Immunotherapy Treated Advanced Non-Small Cell Lung Cancer: A Retrospective Exploratory Study

, , , & ORCID Icon
Pages 29-40 | Received 15 Oct 2023, Accepted 18 Feb 2024, Published online: 25 Mar 2024